succinylcholine. The present results suggest that in the prevention of the haemodynamic responses to tracheal intubation, the half-dose combination of alfentanil and esmolol is as effective as alfentanil and superior to esmolol. The combination is preferable to relatively large doses of either drug in circumstances where side effects, such as respiratory depression due to alfentanil or bradycardia due to both drugs should be minimized.

Ce travail randomis~ en double-aveugle avait pour but l~tude des effets de l'association de l'alfentanil avec l'esmolol ?l demidoses sur l'augmentation de la frdquence cardiaque et de la pression artg, rielle, et sur la prolongation de l~ntervalle QTc de I'ECG pendant l'induction de I'anesthdsie. Soixante patients ASA Iet H dont la moyenne d'age variait entre 25 et 32 ans ont fait partie de l~tude. Ces patients ont dt~ r~partis en quatre groupes pour recevoir respectivement: du solut~ physiologique, de l'esmolol 2 mg" kg -t, de l'alfentanil 0,03 mg" kg -t, et de l'alfentanil 0,015 mg" kg -~ + esmolol 1 mg" kg -1. L'anesth~-sie a ~t~ induite au thiopentone. La succinylcholine a ~td utilisde pour l'intubation. Les pararnktres hdmodynamiques ont ~td enregistrds par voie non effractive et l'intervalle QTc grace ~un micro-ordinateur. Les comparaisons ont ~td ~tablies sur des mesures rdpdtdes par analyse de variance. L'alfentanil et l'alfentanil + esmolol ont emp~chd l'augmentation de la fr~quence cardiaque et de la pression art~rielle caus~e par l'intubation alors que l'esmolol n'a dt~ efficace sur l'augmentation de la fr~quence cardiaque. Aucun des traitements n'a ~t~ efficace pour la prdvention de la prolongation de l'intervalle QTc aprbs l'intubation
It has been shown that alfentanil prevents haemodynamic responses to tracheal intubation, i-3 Alfentanil is a potent opioid with a rapid onset and short duration of action. [4] [5] [6] In addition, the frequency of postoperative nausea and vomiting is less in patients treated with alfentanil than in those treated with another relatively short-acting opioid, fentanyl. 34,35 On the other hand, it is well known from clinical practice that some operations and procedures, especially those concerning the mouth and upper respiratory tract, e.g., tonsillectomy, hypopharyngoscopy, laryngomicroscopy and bronchoscopy, are of brief duration, but cause considerable haemodynamic stimulation. It is possible to perform many of these procedures on an outpatient basis, if the patients do not suffer from postoperative side effects, of which the most disturbing is nausea and vomiting. Therefore, the short-acting alfentanil is preferable for these procedures to other longeracting opioids. However, in some cases, particularly in outpatient anaesthesia, the action of alfentanil might be too long.
Esmolol is a cardioselective, short-acting beta-blocking agent. Previous studies have established the effectiveness of bolus doses of esmolol in the reduction of haemodynamic responses during anaesthetic induction. 7-H However, prevention of the haemodynamic responses to intubation has not been complete. 7-~1 In addition to the haemodynamic responses, we studied the QTc interval of the ECG since it is prolonged during anaesthetic induction, especially after succinylcholine and tracheal intubafion. ~5-1s The clinical importance of the prolongation in patients with normal hearts is not known, but ventricular fibrillation, 24 cardiac arrhythmias 25 and even death 26 have occurred during general anaesthesia in patients suffering from a prolonged QT interval syndrome or an acute myocardial infarction. In earlier studies both alfentani123 and beta-blocking agents practolol and metoprolo116 attenuated the prolongation of the QTc interval during anaesthetic induction.
The present study was designed to compare the effects of alfentanil 30 ~tg. kg-I and esmolol 2 mg-kg-I with those of their half-dose combination on heart rate, arterial pressure and on QTc interval during anaesthetic induction in patients undergoing otolaryngological surgery.
Methods
The study was carded out in 60 ASA class I or II patients without cardiovascular or respiratory disease or any preoperative medication. The mean age of the patients ranged from 26 to 32 yr among groups. The protocol of the study was approved by the Ethics Committee of the Otolaryngological Hospital.
Patients were premedicated with oxycodone (Oxanest| 0.1 mg.kg -1 and atropine (Atropin| 0.01 mg. kg -I im about 60 min before anaesthesia. In this double-blind study, the patients were randomly allocated to one of the four groups: esmolol (Breviblock| 2 mg. kg -I (Esm), alfentanil (Rap[fen| 30 ~g-kg -I (Alf), alfentanil 15 ~g-kg -1 + esmolol 1 rag. kg -I (Alf+Esm) or saline (Sal). The doses of alfentanil and esmolol were chosen on the basis of our preliminary pilot studies as well as earlier studies. I-3,7-11 Either esmolol (Esm) or alfentanil (All) was drawn into two 10 ml syringes (number 1 and number 2), containing half of the calculated dose of the drug in each syringe. In the case of the combination of esmolol and alfentanil (Alf+Esm), esmolol was drawn into a 10 ml syringe, number 1, and alfentanil into another 10 ml syringe, number 2. Thereafter saline was drawn to make up a volume of 10 ml in each syringe. In the Sal group the patients received 20 ml saline in two 10 ml syringes (number 1 and number 2).
At zero time, the study drugs (f~t syringe number 1 and then number 2) were injected over 45 sec. Thiopentone 5 rag. kg -I was started 15 see later and was injected over 45 sec. Succinylcholine 1.5 rag. kg -t was injected 15 see later. Tracheal intubation was performed one minute after succinylcholine. During induction, the patients breathed 100% 0 2 spontaneously until injection of thiopentone. Thereafter, their lungs were ventilated until intubation. The end-tidal CO2% (Datex capnograph) varied between 5-6 vol. % in all groups immediately after intubation.
Systolic and diastolic arterial pressure were automatically measured and registered with a Nippon Colin BP-1001 sphygmomanometer immediately before the injection of the study drugs, at one and two minute as well as about 15 sec and three minutes after intubation. The QT, QRS and ST intervals of the ECG (lead II) were measured by a signal processing method of the ECG at the same time as arterial pressure and, in addition, 30 sec after succinylcholine ( Figure 1 ).
The signal processing method was based on an IBM PC/XT-compatible microcomputer. The other parts of the system were an A/D converter, a board including an amplifier with a gain of three and a low pass fdter with a cut-off frequency of 100 Hz for signal antialiasing. The total system was made compact by inserting all external electronics required into the PC's expansion slots. In each case, the mean QT, QRS and ST intervals of successive beats occurring over ten seconds were determined. After analysis, the results were displayed on the screen and saved on a floppy disk for later examination.
Study dnlg Thio~ntoae Succiaylcholinr Intubadon After intubadon FIGURE I Time line of events and data collection points. X = measurement of heart rate, systolic and diastolic pressure and ECG parameters, (X) = measurements only ECG parameters.
The cycle could be repeated either according to a programmed timetable or manually by the user. Bazett's formula (QT/,v/-R -R) J2 was used for the correction of the QT interval for heart rate. The ECG, lead II, was displayed continuously on an oscilloscope and recorded continuously at every study period. Two-way analysis of variance with repeated measures was used for comparisons among groups. ~3 Paired Student's t test was used for the comparisons within the groups. The P values were adjusted using the Bonferroni multiple testing correction. A P value <0.05 was regarded as statistically significant.
R~
Heart rate
The mean control values of the groups were comparable. Both the drugs (P < 0.01) and the time (P < 0.0001) as well as their interaction (P < 0.0001) markedly affected the results (Figure 2 ). When the groups were compared pairwise, both the All (P < 0.01) and Alf+Esm groups (P < 0.001) differed from the Sat group. Other pairwise comparisons were not significant.
No changes occurred in the Esm, Alf or Alf+Esm groups compared with the corresponding control values. Both immediately and three minutes after intubation, the heart rate increased in the Sat group compared with the corresponding control value (Figure 2) .
Systolic arterial pressure
The mean control values of the groups were comparable. Both the drugs (P < 0.01) and the time (P < 0.0001) as well as their interaction (P < 0.0001) markedly affected the results (Figure 3 ). When the groups were compared pairwise, both the Alf ( P < 0.01) and the Alf+Esm groups (P < 0.01) differed from the Sat group. Other pairwise comparisons were not significant.
After thiopentone, systolic arterial pressure decreased in all groups whereas after intubation, it increased in the Sat and the Esm groups compared with the corresponding control values. Three minutes after intubation, systolic arterial pressure was decreased in the All and Alf § groups compared with the corresponding control values (Figure 3) . FIGURES 2-4 Heart rate, systolic and diastolic arterial pressure in the four anaesthetic groups (means + SEM). Control = just before induction. Study drug = 15 see after injection of study drug. Thiopentone = 15 see after injection of thiopentone. Intubation = 15 see after intubation. After int. = three minutes after intubadon. Fitteen patients in each group. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 compared with the corresponding control value. Comparisons between the groups using two-way ANOVA with repeated measure. Drug-effect for heart rate, systolic and diastolic pressure: P < 0.01, P < 0.01, P < 0.0001, respectively, time-and interaction-effects: for all variables P < 0.0001.
Diastolic arterial pressure
The mean control values of the groups were comparable.
Both the drugs (P < 0.0001) and the time (P < 0.0001) as well as their interaction (P < 0.0001) markedly affected the results (Figure 4 ). When the groups were compared pairwise both the All (P < 0.0001) and the Alf+Esm groups (P < 0.01) differed from the Sal group as well as the Alf (P < 0.001) and the Alf+Esm groups (P < 0.01) from the Esm group.
After thiopentone, diastolic arterial pressure decreased in the All and the Alf+Esm groups whereas after intubation, it increased in the Sal and Esm groups compared with the corresponding control values. Three minutes after intubarion, diastolic arterial pressure decreased in the Alf group compared with the corresponding control value (Figure 4) .
QTc, S T a n d Q R S interval o f the ECG
The mean control values of these variables were comparable in the groups and the mean QTc intervals were in the normal range (<440 msec according to the Bazett's formula). Both the time (P < 0.0001) and its interaction with the drugs (P < 0.0001), but not the drugs alone, affected the QTc interval ( Figure 5 ). When the groups were compared pairwise, the AIf+Esm group differed from the Sal group (P < 0.05). Other pairwise comparisons were not different.
After the study drug, the QTc interval decreased in the Esm and Alf+Esm groups whereas, after succinylcholine, it increased in the Sal, Esm and Alf+Esm groups compared with the corresponding control values. After intubarion, the QTc interval increased in all groups and it remained increased in the Esm and Alf+Esm groups up to three minutes after intubation when compared with the corresponding control values ( Figure 5 ).
The mean control QRS values in the groups were comparable. In the QRS interval, there were no changes within or between the groups (Table I) .
Both the time (P < 0.0001) and its interaction (P < 0.0001) with the drugs, but not the drugs alone, affected the ST interval. None of the pairwise comparisons were significant.
After intubation, the ST interval increased in the Alf+Esm group, whereas three minutes after intubation it decreased in the Sal group compared with the corresponding control values (Table II) .
No cardiac arrhythmias were noticed in any of the groups.
Discussion
Heart rate and arterial pressure In the control of the heart rate and arterial pressure after tracheal intubarion, alfentanil 30 ~tg. kg -~ was a sarisfactory treatment, whereas esmolol 2 mg. k g -' prevented FIGURE 5 QTc intervals in the four anaesthetic groups (means 5: SEM). Control = just before induction, study drug = 15 sec after injection of the study drug, thiopentone = 15 see after injection of thiopentone, succinylcholine = 30 sec after injection of succinylcholine, intubation = 15 sec after intubation. After int. = three minutes after intubation. Fifteen patients in each group. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 compared with the corresponding control value. Comparison using two-way ANOVA with repeated measure. Drug-effect P > 0.05, time-effect P < 0.0001, interactioneffect P < 0.0001. Mean + SEM. N = 15. Sal = saline, Esm = esmolol, All" = alfentanii. Control = prior to induction, study drug = 15 sec after injection of study drug, thiopentone = 15 sec after injection of thiopentone, succinylcholine = 30 sec after injection of suecinylcholine, intubafion = 15 see alter intuhation, After int. = three minutes after intubation.
the increase of the heart rate but not that of arterial pressure. These results are comparable with those obtained in previous studies, t-3,7-11 The present as well as earlier results suggest that alfentanil is useful in the prevention of cardiovascular responses to intubation in circumstances where operations are long enough to avoid postoperative respiratory depression due to alfentanil. However, esmolol 2 mg. k g -' alone was not satisfactory. After intubation, both 15 and 30 0.g" kg -I alfentanil prevented the increase of arterial pressure, but only 30 ~g-kg -m prevented that of the heart rate. ~ In the present study, the combination of alfentanil 15 ~tg. kg-I and es- Comparisons using two-way ANOVA with repeated measure (ST): drug-effect P < 0.05, time-effect P > 0.0001, interaction-effect P < 0.0001. *P < 0.05 compared with the corresponding control values. molol 1 mg. kg -I prevented the increase of both the arterial pressure and heart rate after intubation. Miller et al. 7 reported effective control of both heart rate and arterial pressure by using the combination of esmolol 100 mg and fentanyl 2-3 ~tg. kg -t. Furthermore, similar to the present results, Chung et al. ~4 reported that the combination of fentanyl 2 ~tg. kg-J and esmolol 2 mg. kg-I provided an alternative to a higher dose of fentanyl (5 I~g" kg -t) for preventing the haemodynamic responses to intubation.
The main message of the present study is that it is possible to reduce the dose and also the side effects of alfentanil and esmolol by using their half-dose combination. Alfentanil is a short-acting opioid, but respiratory depression due to alfentanil correlated with dose. 34 Therefore, the dose of alfentanil should be reduced in outpatient anaesthesia or in very short operations with minimal postoperative pain, e.g., microlaryngoscopy and oesophagoscopy. The pharmacodynamic behaviour of alfentanil is similar in both young and elderly patients, 3! but elderly patients tolerate alfentanil less well. 31,32 Therefore, contrary to the present patients who were aged <50 yr and without cardiovascular diseases, the lower dose of alfentanil might be preferable for anaesthesia in elderly patients. Furthermore, both alfentanil and esmolol cause dose-dependent bradycardia. Doses >20 ~g-kg -t alfentanil in combination with succinylcholine caused severe bradycardia and even asystole. 33 Esmolol, 2.5-3 mg. kg -l, reduced the cardiac index and ejection fraction in healthy patients. 30 On this basis, reduction of the dose of esmolol seems to be advantageous. However, it should be remembered that the present results are only applicable to patients receiving anticholinergic premedication.
Q Tc interval
In the present study, the QTc interval decreased in both the esmolol and alfentanil+esmolol groups compared with corresponding control values. This differs from the results obtained by Greenspan and others, 19 who observed no changes in the QTc interval after esmolol infusion. One reason might be the different dosing methods. Furthermore, practolol and metoprolol did not affect the QTc interval. ~6 However, in one study, atenolol induced a marked and constant reduction of the QTc interval 2~ whereas acebutolol 2~ and an unselective beta-receptor blocker sotalol 2~ prolonged the QTc interval. These resuits show that the effect of beta-blockers on the QTc interval is inconsistent.
The present result, that the QTc interval in the saline group was prolonged after succinylcholine and intubation, confLrmS earlier results. 15-ts In the present study esmolol did not prevent prolongation of the QTc interval after succinylcholine and intubation, compared either with the other groups or with the control values within the group. However, practolol 100 ~tg-kg -I and metoprolol 20-40 Isg" kg -j prevented, in a dose-dependent fashion, the prolongation of the QTc interval alter succinylcholine but not that after intubation. J6
In the present study, neither alfentanil nor the halfdose combination of alfentanil and esmolol prevented the prolongation of the QTc interval after intubation. This differs from the results obtained in midazolampremedicated children 22 and in diazepam-meperidinepremedicated adults 23 in whom alfentanil prevented the increase of the QTc interval after both succinylcholine and intubation. However, premedication, the doses of alfentanil and the ages of the patients differed from the present study.
The patients in the present study did not suffer from heart diseases. The importance of prolongation of the QTc interval for the normal heart is controversial. In some studies, there has been a correlation between the prolongation of the QTc interval and the occurrence of cardiac arrhythmias, especially ventricular ectopic beats after laryngoscopy and intubation. 15,1s,22 On the other hand, some investigators have found no correlation between the prolongation of the QTc interval and cardiac arrhythlTlias. 16, 17, 27 Further, d-tubocurarine prevented the prolongation of the QTc interval during anaesthetic induction and decreased the incidence of cardiac arrhythmias. 27 In children, the QTc interval was prolonged during enflurane induction28 but remained unchanged during induction with halothane 29 without cardiac arrhythmias in either of the studies. On this basis, prolongation of the QTc interval otten seems to be related to cardiac arrhythmias, but their appearance might also be affected by the antiarrhythmic properties of the drugs. This is supported by the observation that, despite the prolongation of the QTc interval in the presence of esmolol, there were no cardiac arrhythmias. This may have been due to antiarrhythmic properties of esmolol. 10, 36 It is concluded that the half-dose combination of alfentanil and esmolol prevented the haemodynamic responses to intubation better than esmolol 2 rag. kg -l and the prevention was comparable with that by alfentanil 30 vtg" kg-k None of the treatments prevented prolongation of the QTc interval during anaesthetic induction. It is possible to control haemodynamic responses during anaesthetic induction by reducing the dosage and also side effects of alfentanil and esmolol by using them together.
